In 2019, Antibiotice Iasi recorded the highest growth rate of export sales in the last 5 years. Last year, the exports accounted for 40 percent of company’s turnover, reaching 152,1 million RON, 25 percent higher than the value recorded in 2018.

This growth has been the fastest rate in the last five years. 2019 was the first year in which the sales of finished products in the international markets significantly outpaced the sales of the active substance Nystatin.

The main growth engine was the export of finished products in the territories where Antibiotice opened its own representative offices, the value of these exports recording an increase past 65 percent compared to 2018, reaching a value of 44.4 million RON.

In the domestic market, Antibiotice recorded sales comparable to the sales recorded in 2018, both in pharmacies and hospitals, amounting to 335.9 million RON.